| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 02/08/2011 | US7884179 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 02/08/2011 | US7884081 Methods of modulating tubulin deacetylast activity |
| 02/08/2011 | US7883687 15O-labeled monosaccharide and producing method thereof |
| 02/03/2011 | WO2011013703A1 Pancreatic endocrine cell indicator and utilization of same |
| 02/03/2011 | WO2011012435A2 Active ingredient and method for testing an active ingredient |
| 02/03/2011 | US20110028714 Folate mimetics and folate-receptor binding conjugates thereof |
| 02/03/2011 | US20110027179 Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy |
| 02/03/2011 | US20110027178 Imaging the central nervous system |
| 02/03/2011 | US20110027177 Inhibition of angiogenesis |
| 02/03/2011 | US20110027176 Homing peptide for tumor vasculature |
| 02/03/2011 | US20110027175 Cancer imaging and treatment |
| 02/03/2011 | US20110027174 Nanotubes for cancer therapy and diagnostics |
| 02/03/2011 | US20110027173 Ephrin type-a receptor 10 protein |
| 02/03/2011 | US20110027172 Drug delivery system for pharmaceuticals and radiation |
| 02/03/2011 | US20110027171 Ph sensitive liposome composition |
| 02/03/2011 | DE102009035649A1 Arzneistoff und Verfahren zur Erprobung eines Arzneistoffes Drug and method for testing a drug |
| 02/03/2011 | CA2769754A1 Folate-targeted diagnostics and treatment |
| 02/02/2011 | EP2279759A2 Compounds and methods for 18F labeled agents |
| 02/02/2011 | EP2279757A2 Compounds for targeting endothelial cells |
| 02/02/2011 | EP2279190A1 Compounds comprising paramagnetic chelates arranged around a central core and their use in magneto resonance imaging and spectroscopy |
| 02/02/2011 | EP2279011A2 Substrate based pet imaging agents |
| 02/02/2011 | CN101965358A Bombesin analog peptide antagonist conjugates |
| 02/02/2011 | CN101961496A Cancerous disease modifying antibodies |
| 02/02/2011 | CN101260147B Modified blood vessel endothelium growth factor polypeptide segment and application thereof |
| 02/01/2011 | US7879313 Nanoparticles for protein drug delivery |
| 02/01/2011 | US7879312 Nanoparticles for protein drug delivery |
| 01/27/2011 | WO2011011592A1 Methods for generating radioimmunoconjugates |
| 01/27/2011 | WO2011009539A1 ε-POLYLYSINE CONJUGATES AND USE THEREOF |
| 01/27/2011 | WO2010043218A3 Tetrathiol ligands, metal complexes, conjugates, and kits, the use thereof in nuclear medicine diagnostics and endoradionuclide therapy, and method for producing the tetrathiol ligands and metal complexes |
| 01/27/2011 | WO2009140210A9 Radiotracers for imaging cannabinoid sub-type1 (cb1) receptor |
| 01/27/2011 | US20110020224 Apparatus and method for preparing medicines containing radioactive substances |
| 01/27/2011 | US20110020223 Polypeptides having affinity for her2 |
| 01/27/2011 | US20110020222 Modified antibodies and methods of use |
| 01/27/2011 | US20110020221 Cancer stem cell expression patterns and compounds to target cancer stem cells |
| 01/27/2011 | US20110020220 Humanized antibodies against the beta-amyloid peptide |
| 01/27/2011 | US20110020219 Anti-human tenascin monoclonal antibody |
| 01/27/2011 | US20110020218 Novel anti cxcr4 antibodies and their use for the treatment of cancer |
| 01/27/2011 | US20110020217 Treatment of melanoma |
| 01/27/2011 | US20110020216 Scaffolds for cell collection or elimination |
| 01/27/2011 | CA2768658A1 Methods for generating radioimmunoconjugates |
| 01/27/2011 | CA2768547A1 E-polylysine conjugates and use thereof |
| 01/27/2011 | CA2768466A1 Hdac inhibitors and therapeutic methods using the same |
| 01/26/2011 | EP2277547A1 Epsilon-polylysine conjugates and their utilisation |
| 01/26/2011 | EP2277542A1 Modified antibodies to prostrate-specific membrane antigen and uses thereof |
| 01/26/2011 | EP2277507A1 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 01/26/2011 | EP2276779A1 Use of a radioactively labelled molecule specifically binding to ed-b fibronectin in a method of hodgkin lymphoma |
| 01/26/2011 | EP2276752A1 Compound composed of a metal ion and a marker precursor having two or more targeting vectors, and use of the compound |
| 01/26/2011 | CN101954097A Novel 18F labeled substituted benzimidazole compounds, preparation method thereof and PET tumor imaging application |
| 01/26/2011 | CN101272809B Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents |
| 01/25/2011 | US7875701 Diagnostic compounds |
| 01/25/2011 | US7875612 Folate mimetics and folate-receptor binding conjugates thereof |
| 01/25/2011 | US7875454 Exposing the tissue to ionizing radiation; administering a delivery vehicle, platelets; leukocytes; proteins or peptides of the active agent; treating neoplasms, cancers, tumors |
| 01/25/2011 | US7875287 Tc-labeled arylpiperazine derivatives for imaging serotonin receptor |
| 01/25/2011 | US7875279 intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis are enriched by deleting or inactivating genes; asthma, morbus Crohn, colitis ulcerosa, multiple sclerosis and chronic bronchitis and immune and auto-immune diseases and allergies and bone diseases and osteoporosis |
| 01/25/2011 | US7875258 For use as radiopharmaceuticals; solid phase synthesis; conjugation with DNA and G-protein-coupled receptors; high binding affinity, high labeling yield, superior retention and versatility; labeling without the need for co-ligands; simplification |
| 01/25/2011 | CA2476983C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma |
| 01/25/2011 | CA2453278C Diagnostic agents for pancreatic exocrine function |
| 01/25/2011 | CA2333833C Specific binding molecules for scintigraphy,conjugates containing them and therapeutic method for treatment of angiogenesis |
| 01/20/2011 | WO2011009035A1 Method for in vivo measurement of reverse cholesterol transport |
| 01/20/2011 | WO2011006510A1 Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines |
| 01/20/2011 | WO2010125068A3 Labeled molecular imaging agents, methods of making and methods of use |
| 01/20/2011 | WO2010118706A4 Method for obtaining novel derivatives of naphthalene for the in vivo diagnosis of alzheimer's disease |
| 01/20/2011 | US20110015437 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 01/20/2011 | US20110014121 Modulators of cxcr7 |
| 01/20/2011 | US20110014120 Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging |
| 01/20/2011 | US20110014119 Methods for Manipulating Phagocytosis Mediated by CD47 |
| 01/20/2011 | US20110014118 Nanotherapeutic colloidal metal compositions and methods |
| 01/20/2011 | US20110014117 Anti-igf1r |
| 01/20/2011 | CA2768444A1 Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines |
| 01/19/2011 | EP2275548A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 01/19/2011 | EP2275145A1 Reagents and methods for radiolabelling of RGD-containing peptides |
| 01/19/2011 | EP2275136A1 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody |
| 01/19/2011 | EP2274312A2 Metal complexes |
| 01/19/2011 | EP2274018A1 Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties |
| 01/19/2011 | CN101952433A PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 01/19/2011 | CN101952302A New polypeptides having affinity for HER2 |
| 01/19/2011 | CN101951965A Methods and devices for minimally-invasive extraocular delivery of radiation to the posterior portion of the eye |
| 01/19/2011 | CN101951964A Imaging method |
| 01/19/2011 | CN101948380A Perturbed membrane-binding compounds and methods of using the same |
| 01/19/2011 | CN101333138B Device and process capable of simultaneously preparing three different <18>F radiopharmaceuticals |
| 01/18/2011 | US7871623 administering imaging composition comprising labeled annexin coupled to biocompatible radionuclide such as Technetium 99 |
| 01/18/2011 | CA2408008C Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
| 01/13/2011 | WO2011006088A2 Fluorine containing compounds and methods of use thereof |
| 01/13/2011 | WO2011005916A1 Nanoparticle compositions comprising a lipid bilayer and associated methods |
| 01/13/2011 | WO2010135431A3 Compositions, devices, and methods related to prostate-specific membrane antigen |
| 01/13/2011 | WO2010066843A3 Biomolecule complexes as contrast agents in positron emission tomography (pet) based methods for the assessment of organ function |
| 01/13/2011 | WO2009112823A8 Metal complexes |
| 01/13/2011 | US20110009605 Novel contrast agents |
| 01/13/2011 | US20110009343 Modulators of amyloid aggregation |
| 01/13/2011 | US20110008338 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008337 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008336 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008254 Radiopharmaceutical composition |
| 01/13/2011 | US20110008253 Process for production of heterodimers of glutamic acid |
| 01/13/2011 | US20110008252 Stabalised 99mtc compositions |
| 01/13/2011 | US20110008251 Methods for Generating Stably Linked Complexes Composed of Homodimers, Homotetramers or Dimers of Dimers and Uses |
| 01/13/2011 | US20110008250 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008249 Proteins with high immunoreactivity and method for their production |
| 01/13/2011 | US20110008248 Peptide Antagonists of TGF-Beta Family Members and Therapeutic Uses Thereof |
| 01/13/2011 | US20110005518 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |